Tenere Capital’s Bio-Techne TECH Stock Holding History

Tenere Capital’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-160,245	Closed	-$12.8M	–	30
2024 Q3	$12.8M	Buy	160,245 +45,992	+40%	+$3.46M	3.4%	16
2024 Q2	$8.19M	Buy	114,253 +1,921	+2%	+$141K	2.43%	23
2024 Q1	$7.91M	Buy	+112,332	New	+$8.04M	2.35%	23

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Tenere Capital's TECH Position: Q4 2024 in Review

Tenere Capital sold out of Bio-Techne (TECH) in Q4 2024, closing a stake of 160,245 shares — an estimated $12.8M sold.

Tenere Capital first reported a position in TECH in Q1 2024 and held it in 3 quarters. The position peaked at $12.8M in Q3 2024. 577 funds tracked by Wall St. Rank hold TECH as of Q4 2024.

Tenere Capital reported no remaining Bio-Techne position as of Q4 2024 after selling out during the quarter.
Tenere Capital sold 160,245 Bio-Techne shares in Q4 2024, an estimated $12.8M.
Tenere Capital first reported a position in Bio-Techne in Q1 2024 and held it in 3 quarters.
Tenere Capital's Bio-Techne position peaked at $12.8M in Q3 2024.
577 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2024.

Based on Tenere Capital's 13F filing for Q4 2024, filed 14 Feb 2025.